Active ingredients: zoledronic acid
What it is used for
Treatment of osteoporosis in postmenopausal women to reduce the incidence of hip, vertebral and nonvertebral fractures.,Treatment of osteoporosis in patients over 50 years of age with a history of at least one low trauma hip fracture, to reduce the incidence of further fractures.,To increase bone mineral density in men with osteoporosis.,To increase bone mineral density in patients with osteoporosis associated with long term glucocorticoid use.,To prevent glucocorticoid-induced bone mineral density loss.,Treatment of Paget's disease of bone.
How to take it
The way to take this medicine is: Intravenous Infusion.
- Store below 25 degrees Celsius
- Shelf lifetime is 18 Months.
Always read the label. If symptoms persist see your healthcare professional.
Clear, colourless solution in a clear, colourless bag with one port and connector with a grey rubber membrane.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient zoledronic acid
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems